rs11556620
Variant summary
Our verdict is Pathogenic. The variant received 17 ACMG points: 17P and 0B. PM1PM2PP2PP3_StrongPP5_Very_Strong
The NM_000454.5(SOD1):c.260A>G(p.Asn87Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,461,702 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_000454.5 missense
Scores
Clinical Significance
Conservation
Publications
- amyotrophic lateral sclerosis type 1Inheritance: AD, AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- spastic tetraplegia and axial hypotonia, progressiveInheritance: AR Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- amyotrophic lateral sclerosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 17 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SOD1 | NM_000454.5 | c.260A>G | p.Asn87Ser | missense_variant | Exon 4 of 5 | ENST00000270142.11 | NP_000445.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461702Hom.: 0 Cov.: 30 AF XY: 0.00000275 AC XY: 2AN XY: 727176 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Amyotrophic lateral sclerosis type 1 Pathogenic:4
The highest population allele frequency in gnomAD v4.0 is 0.00002196 (0.0022%; 2/91080 alleles in the South Asian population). No homozygous observations. PM1_Supporting: Exon 4 is a well-established catalytic domain, other pathogenic missense variants reported at adjacent amino acids (PMID: 17299743, 20309572). PP3_Moderate: Revel score is 0.853. PS4_Met: Variant observed in more than 10 unrelated probands with consistent phenotype for disorder (PMID: 9556377; 20577002; 22244934; 26601740; 26622980; 27604643). PM5 Met: Different missense changes at the same codon reported to be pathogenic (p.Asn87Asp, p.Asn87Lys). -
This sequence change replaces asparagine, which is neutral and polar, with serine, which is neutral and polar, at codon 87 of the SOD1 protein (p.Asn87Ser). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with autosomal recessive juvenile-onset amyotrophic lateral sclerosis (ALS) and autosomal dominant ALS (PMID: 8971099, 9556377, 20577002, 22244934, 26601740, 26622980, 27604643). ClinVar contains an entry for this variant (Variation ID: 468253). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt SOD1 protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic. -
The variant is not observed in the gnomAD v2.1.1 dataset. The variant is located in a mutational hot spot and/or well-established functional domain in which established pathogenic variants have been reported. Missense changes are a common disease-causing mechanism. In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.85; 3Cnet: 0.97). Same nucleotide change resulting in same amino acid change has been previously reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000468253 / PMID: 9556377). Different missense changes at the same codon (p.Asn87Asp, p.Asn87Lys) have been reported to be associated with SOD1 -related disorder (PMID: 17299743, 20309572). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline. -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at